Lishan Aklog compensation by year
Lucid Diagnostics Summary Compensation Table · all 5 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Salary | $0 | $0 | $300,000 | $300,000 | $300,000 |
| Bonus | $0 | $0 | $0 | $0 | $150,000 |
| Stock awards | $7,280,000 | $271,200 | $0 | $412,000 | $447,000 |
| Option awards | $0 | $184,500 | $0 | $0 | $0 |
| Non-equity incentive | $0 | $0 | $0 | $0 | $0 |
| Pension and deferred compensation | $0 | $0 | $0 | $0 | $0 |
| All other | $0 | $0 | $0 | $0 | $0 |
| Total | $7,280,000 | $455,700 | $300,000 | $712,000 | $897,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lucid Diagnostics Inc. DEF 14A filed April 30, 2026, accession 0001493152-26-020708, and prior-year filings.
How this page was built: the Lucid Diagnostics Inc. filed document, accession 0001493152-26-020708. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 1,324,400 | $1,443,596 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Lucid Diagnostics Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Lucid Diagnostics’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Lishan Aklog · this page | Chairman of the Board and Chief Executive Officer | $897,000 |
| Shaun O’Neil | President and Chief Operating Officer | $822,000 |
| Michael Gordon | General Counsel and Corporate Secretary | $759,500 |
| Dennis McGrath | Chief Financial Officer | $750,750 |
Board service
Lucid Diagnostics board · FY2023How this board is paid
Company policy: Lucid Diagnostics pays directors a $50,000 cash retainer and $150,000 in Options. As stated in Lucid Diagnostics's FY2023 proxy.
Committees
Technology, Compliance and Quality
The full Lucid Diagnostics compensation record
free company briefThis page is one person within Lucid Diagnostics's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Lucid Diagnostics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.